US Patent Issued to Endothelium Scanning Nanotechnology on Jan. 13 for "Biomarker and drug combinations for heart failure prediction" (Australian Inventors)

ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,521,402, issued on Jan. 13, was assigned to Endothelium Scanning Nanotechnology Ltd. (Melbourne, Australia).

"Biomarker and drug combinations for heart failure prediction" was invented by Leopoldt De Bruin (Balwyn, Australia), Gustav De Bruin (Highton, Australia) and Andrew Coats (Richmond, Australia).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are methods and compositions for the detection of biomarkers for cardiac diseases. Disclosed herein are sample collection devices comprising detection devices for heart failure. Disclosed herein are methods of detecting, monitoring, preventing, or treating heart failure."

The patent was filed ...